WHO ICTRP trial

A clinical study for probiotics in the regulation of intestinal function and…

ChiCTR2000029999 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2000029999
Public title A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19)
Scientific title A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19)
Primary sponsor Shanghai 10th people's hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions novel coronavirus pneumonia
Interventions Mild Group:probiotics;Severe Group:probiotics
Registration date Feb 19, 2020
Target size Mild Group:30;Severe Group:30
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations